{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:59:55Z","timestamp":1781053195119,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05855-0","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:24:00Z","timestamp":1776817440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning combined with multi-omics analysis: identifying nucleotide metabolism-associated immune genes and validating their functions in cardiomyopathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Pei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbang","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"5855_CR1","doi-asserted-by":"publisher","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503\u20133626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"5855_CR2","doi-asserted-by":"publisher","unstructured":"Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci. 2021;22(14):7722. https:\/\/doi.org\/10.3390\/ijms22147722","DOI":"10.3390\/ijms22147722"},{"key":"5855_CR3","doi-asserted-by":"publisher","unstructured":"Lane AN, Fan TW. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015;43(4):2466-85. https:\/\/doi.org\/10.3390\/ijms22147722","DOI":"10.3390\/ijms22147722"},{"key":"5855_CR4","doi-asserted-by":"publisher","unstructured":"Diehl FF, Miettinen TP, Elbashir R, Nabel CS, Darnell AM, Do BT et al. Nucleotide imbalance decouples cell growth from cell proliferation. Nat Cell Biol. 2022;24(8):1252\u20131264. https:\/\/doi.org\/10.1038\/s41556-022-00965-1","DOI":"10.1038\/s41556-022-00965-1"},{"key":"5855_CR5","doi-asserted-by":"publisher","unstructured":"Lopez-Schenk R, Collins NL, Schenk NA, Beard DA. Integrated Functions of Cardiac Energetics, Mechanics, and Purine Nucleotide Metabolism. Compr Physiol. 2023;14(1):5345\u20135369. https:\/\/doi.org\/10.1002\/cphy.c230011","DOI":"10.1002\/cphy.c230011"},{"key":"5855_CR6","doi-asserted-by":"publisher","unstructured":"Ussher JR, Jaswal JS, Lopaschuk GD. Pyridine nucleotide regulation of cardiac intermediary metabolism. Circ Res. 2012;111(5):628\u2009\u2013\u200941. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246371","DOI":"10.1161\/CIRCRESAHA.111.246371"},{"key":"5855_CR7","doi-asserted-by":"publisher","unstructured":"Dwenger MM, Raph SM, Reyzer ML, Lisa Manier M, Riggs DW, Wohl ZB et al. Pyridine nucleotide redox potential couples myocardial blood flow to metabolism in coronary smooth muscle. Nat Commun. 2022;13:2051. https:\/\/doi.org\/10.1038\/s41467-022-29745-z","DOI":"10.1038\/s41467-022-29745-z"},{"issue":"3","key":"5855_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2021.12.016","volume":"136","author":"JP Dewulf","year":"2022","unstructured":"Dewulf JP, Marie S, Nassogne MC. Disorders of purine biosynthesis metabolism. Mol Genet Metab. 2022;136(3):190\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.016.","journal-title":"Mol Genet Metab"},{"key":"5855_CR9","doi-asserted-by":"publisher","unstructured":"Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX et al. Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy. J Mol Med (Berl). 2022;100(12):1721\u20131739. https:\/\/doi.org\/10.1007\/s00109-022-02269-1","DOI":"10.1007\/s00109-022-02269-1"},{"key":"5855_CR10","doi-asserted-by":"publisher","unstructured":"Antonioli L, Fornai M, Pellegrini C, Pacher P, Hask\u00f3 G. Adenosine signaling as target in cardiovascular pharmacology. Curr Opin Pharmacol. 2023;71:102393. https:\/\/doi.org\/10.1016\/j.coph.2023.102393","DOI":"10.1016\/j.coph.2023.102393"},{"key":"5855_CR11","doi-asserted-by":"publisher","unstructured":"Du H, Zhao Y, Wen J, Dai B, Hu G, Zhou Y et al. LncRNA DCRT protects against dilated cardiomyopathy by regulating NDUFS2 splicing via PTBP1 binding. Circulation. 2024;150(13):1030\u20131049. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067861","DOI":"10.1161\/CIRCULATIONAHA.123.067861"},{"key":"5855_CR12","doi-asserted-by":"publisher","unstructured":"Gao J, Shao CL, Meng XB, Wang WY, Zhang K, Wang JJ et al. Uric acid correlates with cardiac death in hypertrophic obstructive cardiomyopathy. J Geriatr Cardiol. 2021;18(4):281\u2013288. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2021.04.006","DOI":"10.11909\/j.issn.1671-5411.2021.04.006"},{"key":"5855_CR13","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","DOI":"10.1093\/nar\/gkv007"},{"key":"5855_CR14","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"5855_CR15","doi-asserted-by":"publisher","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","DOI":"10.1186\/1471-2105-9-559"},{"key":"5855_CR16","doi-asserted-by":"publisher","unstructured":"Benjamin KJM, Katipalli T, Paquola ACM. dRFEtools: dynamic recursive feature elimination for omics. Bioinformatics. 2023;39(8):btad513. https:\/\/doi.org\/10.1093\/bioinformatics\/btad513","DOI":"10.1093\/bioinformatics\/btad513"},{"key":"5855_CR17","doi-asserted-by":"publisher","unstructured":"Becker T, Rousseau AJ, Geubbelmans M, Burzykowski T, Valkenborg D. Decision trees and random forests. Am J Orthod Dentofacial Orthop. 2023;164(6):894\u2013897. https:\/\/doi.org\/10.1016\/j.ajodo.2023.09.011","DOI":"10.1016\/j.ajodo.2023.09.011"},{"key":"5855_CR18","doi-asserted-by":"publisher","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33(1):1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01","DOI":"10.18637\/jss.v033.i01"},{"key":"5855_CR19","doi-asserted-by":"publisher","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77","DOI":"10.1186\/1471-2105-12-77"},{"key":"5855_CR20","doi-asserted-by":"publisher","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-50. https:\/\/doi.org\/10.1073\/pnas.0506580102","DOI":"10.1073\/pnas.0506580102"},{"key":"5855_CR21","doi-asserted-by":"publisher","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453-7. https:\/\/doi.org\/10.1038\/nmeth.3337","DOI":"10.1038\/nmeth.3337"},{"key":"5855_CR22","doi-asserted-by":"publisher","unstructured":"Liu Y, Zhang W, Hu T, Ni J, Xu B, Huang W. A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo. J Vis Exp. 2020(159). https:\/\/doi.org\/10.3791\/61158.","DOI":"10.3791\/61158"},{"key":"5855_CR23","doi-asserted-by":"publisher","unstructured":"Fan R, Yan X, Zhang W. Relationship between asporin and extracellular matrix behavior: A literature review. Medicine (Baltimore). 2022;101(51):e32490. https:\/\/doi.org\/10.1097\/MD.0000000000032490","DOI":"10.1097\/MD.0000000000032490"},{"key":"5855_CR24","doi-asserted-by":"publisher","unstructured":"Huang C, Sharma A, Thakur R, Rai D, Katiki M, Germano JF et al. Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling. Matrix Biol. 2022;110:40\u201359. https:\/\/doi.org\/10.1016\/j.matbio.2022.04.005","DOI":"10.1016\/j.matbio.2022.04.005"},{"key":"5855_CR25","doi-asserted-by":"publisher","unstructured":"Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N, Sun W et al. Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts. JCI Insight. 2023;8(9):e168655. https:\/\/doi.org\/10.1172\/jci.insight.168655","DOI":"10.1172\/jci.insight.168655"},{"key":"5855_CR26","doi-asserted-by":"publisher","unstructured":"Wang HB, Huang R, Yang K, Xu M, Fan D, Liu MX et al. Identification of differentially expressed genes and preliminary validations in cardiac pathological remodeling induced by transverse aortic constriction. Int J Mol Med. 2019;44(4):1447\u20131461. https:\/\/doi.org\/10.3892\/ijmm.2019.4291","DOI":"10.3892\/ijmm.2019.4291"},{"key":"5855_CR27","doi-asserted-by":"publisher","unstructured":"Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN. Lumican, a small leucine-rich proteoglycan. IUBMB Life. 2008;60(12):818\u2009\u2013\u200923. https:\/\/doi.org\/10.1002\/iub.131","DOI":"10.1002\/iub.131"},{"key":"5855_CR28","doi-asserted-by":"publisher","unstructured":"Huang X, Zhao X, Li Y, Feng Y, Zhang G, Wang Q et al. Combining Bulk and Single Cell RNA-Sequencing Data to Identify Hub Genes of Fibroblasts in Dilated Cardiomyopathy. J Inflamm Res. 2024;17:5375\u20135388. https:\/\/doi.org\/10.2147\/JIR.S470860","DOI":"10.2147\/JIR.S470860"},{"key":"5855_CR29","doi-asserted-by":"publisher","unstructured":"Zheng PF, Liu F, Zheng ZF, Pan HW, Liu ZY. Identification MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 as the potential immune-related key genes involved in ischaemic cardiomyopathy by random forest and nomogram. Aging (Albany NY). 2023;15(5):1475\u20131495. https:\/\/doi.org\/10.18632\/aging.204547","DOI":"10.18632\/aging.204547"},{"key":"5855_CR30","doi-asserted-by":"publisher","unstructured":"Rixon C, Andreassen K, Shen X, Erusappan PM, Almaas VM, Palmero S et al. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy. ESC Heart Fail. 2023;10(2):858\u2013871. https:\/\/doi.org\/10.1002\/ehf2.14234","DOI":"10.1002\/ehf2.14234"},{"key":"5855_CR31","doi-asserted-by":"publisher","unstructured":"Clausen T, Southan C, Ehrmann M. The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell. 2002;10(3):443\u2009\u2013\u200955. https:\/\/doi.org\/10.1016\/s1097-2765(02)00658-5","DOI":"10.1016\/s1097-2765(02)00658-5"},{"key":"5855_CR32","doi-asserted-by":"publisher","unstructured":"Clausen T, Kaiser M, Huber R, Ehrmann M. HTRA proteases: regulated proteolysis in protein quality control. Nat Rev Mol Cell Biol. 2011;12(3):152\u2009\u2013\u200962. https:\/\/doi.org\/10.1038\/nrm3065","DOI":"10.1038\/nrm3065"},{"key":"5855_CR33","doi-asserted-by":"publisher","unstructured":"Song S, Li X, Xue X, Dong W, Li C. Progress in the Study of the Role and Mechanism of HTRA1 in Diseases Related to Vascular Abnormalities. Int J Gen Med. 2024;17:1479\u20131491. https:\/\/doi.org\/10.2147\/IJGM.S456912","DOI":"10.2147\/IJGM.S456912"},{"key":"5855_CR34","doi-asserted-by":"publisher","unstructured":"Su J, Gao C, Wang R, Xiao C, Yang M. Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population. Mol Med Rep. 2018;18(2):1311\u20131322. https:\/\/doi.org\/10.3892\/mmr.2018.9077","DOI":"10.3892\/mmr.2018.9077"},{"key":"5855_CR35","doi-asserted-by":"publisher","unstructured":"Ikawati M, Kawaichi M, Oka C. Loss of HtrA1 serine protease induces synthetic modulation of aortic vascular smooth muscle cells. PLoS One. 2018;13(5):e0196628. https:\/\/doi.org\/10.1371\/journal.pone.0196628","DOI":"10.1371\/journal.pone.0196628"},{"key":"5855_CR36","doi-asserted-by":"publisher","unstructured":"Shi H, Yuan M, Cai J, Lan L, Wang Y, Wang W et al. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy. J Transl Med. 2024;22(1):297. https:\/\/doi.org\/10.1186\/s12967-024-05098-7","DOI":"10.1186\/s12967-024-05098-7"},{"key":"5855_CR37","doi-asserted-by":"publisher","unstructured":"Zhao X, Ren Y, Ren H, Wu Y, Liu X, Chen H et al. The mechanism of myocardial fibrosis is ameliorated by myocardial infarction-associated transcript through the PI3K\/Akt signaling pathway to relieve heart failure. J Int Med Res. 2021;49(7):3000605211031433. https:\/\/doi.org\/10.1177\/03000605211031433","DOI":"10.1177\/03000605211031433"},{"key":"5855_CR38","doi-asserted-by":"publisher","unstructured":"Qin W, Cao L, Massey IY. Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476(11):4045\u20134059. https:\/\/doi.org\/10.1007\/s11010-021-04219-w","DOI":"10.1007\/s11010-021-04219-w"},{"key":"5855_CR39","doi-asserted-by":"publisher","unstructured":"Li L, Zhao Q, Kong W. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 2018;68\u201369:490\u2013506. https:\/\/doi.org\/10.1016\/j.matbio.2018.01.013","DOI":"10.1016\/j.matbio.2018.01.013"},{"key":"5855_CR40","doi-asserted-by":"publisher","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600-4. https:\/\/doi.org\/10.3109\/10799893.2015.1030412","DOI":"10.3109\/10799893.2015.1030412"},{"key":"5855_CR41","doi-asserted-by":"publisher","unstructured":"Chen S, Fan H, Ran C, Hong Y, Feng H, Yue Z et al. The IL-17 pathway intertwines with neurotrophin and TLR\/IL-1R pathways since its domain shuffling origin. Proc Natl Acad Sci U S A. 2024;121(19):e2400903121. https:\/\/doi.org\/10.1073\/pnas.2400903121","DOI":"10.1073\/pnas.2400903121"},{"key":"5855_CR42","doi-asserted-by":"publisher","unstructured":"Guerra-de-Blas PDC, Cruz-Gonz\u00e1lez D, Mart\u00ednez-Shio EB, Gonz\u00e1lez-Amaro R, Gonz\u00e1lez-Pacheco H, Layseca-Espinosa E et al. Altered Phenotype of Circulating Dendritic Cells and Regulatory T Cells from Patients with Acute Myocarditis. J Immunol Res. 2022;2022:8873146 https:\/\/doi.org\/10.1155\/2022\/8873146","DOI":"10.1155\/2022\/8873146"},{"key":"5855_CR43","doi-asserted-by":"publisher","unstructured":"Zhang K, Li Y, Ge X, Meng L, Kong J, Meng X. (2024). Regulatory T cells protect against diabetic cardiomyopathy in db\/db mice. J Diabetes Investig. 2024;15(9):1191\u20131201. https:\/\/doi.org\/10.1111\/jdi.14251","DOI":"10.1111\/jdi.14251"},{"key":"5855_CR44","doi-asserted-by":"publisher","unstructured":"Alexander JP, Cravatt BF. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc. 2006;128(30):9699\u20139704. https:\/\/doi.org\/10.1021\/ja062999h","DOI":"10.1021\/ja062999h"},{"key":"5855_CR45","doi-asserted-by":"publisher","unstructured":"Marz\u0119da P, Wr\u00f3blewska-\u0141uczka P, Florek-\u0141uszczki M, G\u00f3ralczyk A, \u0141uszczki JJ. Antiproliferative effects of LY-2183240 combined with various chemotherapeutic drugs in an isobolographic in vitro model of malignant melanoma. Eur J Pharmacol. 2024;982:176937. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176937","DOI":"10.1016\/j.ejphar.2024.176937"},{"key":"5855_CR46","doi-asserted-by":"publisher","unstructured":"Powers MS, Barrenha GD, Mlinac NS, Barker EL, Chester JA. Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference. Psychopharmacology (Berl). 2010;212(4):571\u2013583. https:\/\/doi.org\/10.1007\/s00213-010-1997-2","DOI":"10.1007\/s00213-010-1997-2"},{"key":"5855_CR47","doi-asserted-by":"publisher","unstructured":"Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Baker SJ, Papathi N, Jiang J, Holland J, Reddy EP. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 2005;7(3):275\u2013286. https:\/\/doi.org\/10.1016\/j.ccr.2005.02.009","DOI":"10.1016\/j.ccr.2005.02.009"},{"key":"5855_CR48","doi-asserted-by":"publisher","unstructured":"Prasad A, Khudaynazar N, Tantravahi RV, Gillum AM, Hoffman BS. ON 01910.Na (rigosertib) inhibits PI3K\/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines. Oncotarget. 2016;7(48):79388\u201379400. https:\/\/doi.org\/10.18632\/oncotarget.12692","DOI":"10.18632\/oncotarget.12692"},{"key":"5855_CR49","doi-asserted-by":"publisher","unstructured":"Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, Collins R Jr, Kantarjian H, Jabbour E, Wilhelm FE, Azarnia N, Silverman LR, ONTIME study investigators. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. Lancet Oncol. 2016;17(4):496\u2013508. https:\/\/doi.org\/10.1016\/S1470-2045(16)00009-7","DOI":"10.1016\/S1470-2045(16)00009-7"},{"key":"5855_CR50","doi-asserted-by":"publisher","unstructured":"Komrokji RS, Raza A, Lancet JE, Ren C, Taft D, Maniar M, Wilhelm F, List AF. Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes. Br J Haematol. 2013;162(4):517\u2013524. https:\/\/doi.org\/10.1111\/bjh.12436","DOI":"10.1111\/bjh.12436"},{"key":"5855_CR51","doi-asserted-by":"publisher","unstructured":"Sanguinetti MC, Mitcheson JS. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci. 2005;26(3):119\u2013124. https:\/\/doi.org\/10.1016\/j.tips.2005.01.003","DOI":"10.1016\/j.tips.2005.01.003"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05855-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05855-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:29:35Z","timestamp":1781051375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05855-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5855"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05855-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals (published by the National Institutes of Health, USA, 8th edition, 2011) and the ethical standards of the Animal Ethics Committee of Kangtai Medical Laboratory Service Hebei Co., Ltd. The experimental protocol was reviewed and formally approved by this committee (Approval Number: MDL2025-07-23-02; Approval Date: 2025-07-20). All efforts were made to minimize the number of laboratory animals used and alleviate their potential suffering: for example, sterile operation techniques were adopted during sample collection to avoid infection, and euthanasia was performed via carbon dioxide inhalation in accordance with the AVMA Guidelines for the Euthanasia of Animals (2020 edition) when necessary. Public databases used in this study are publicly available resources, and therefore no additional authorization is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}